Thank you Opportunity. I do enjoy ferreting out information and at times, it can prove to be very profitable. We have a unique situation here. Biocurex cannot really comment yet on the presentations until the abstracts come out in Tumor Biology and Abbott doesn't need to comment for any reason yet either so until we get something official, the stock price will be a huge, huge bargain. The fact that the presentations are on the program at the ISOBM gives us iron clad information on things to come.
Have a good weekend and get ready for more action on Monday.
News 
Market Data 
Discover 
